Alnylam Pharmaceuticals ALNY
Last Price
52 Week Range
$205.87 - $495.55
Next Earnings Date
Feb 12 2026 (Estimate)
Next Earnings Date
Feb 12 2026 (Est.)
Last Price
ALNY Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Alnylam Pharmaceuticals, Inc. | 8-K | December 11, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | December 3, 2025 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | October 30, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | October 30, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | October 3, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | September 12, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | September 10, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | July 31, 2025 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | July 31, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | June 18, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | May 13, 2025 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | May 1, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | May 1, 2025 | |
Alnylam Pharmaceuticals, Inc. | DEFA14A | April 4, 2025 | |
Alnylam Pharmaceuticals, Inc. | DEF 14A | March 24, 2025 | |
Alnylam Pharmaceuticals, Inc. | DEFA14A | March 24, 2025 | |
Alnylam Pharmaceuticals, Inc. | ARS | March 24, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | March 21, 2025 | |
Alnylam Pharmaceuticals, Inc. | PRE 14A | March 14, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | March 5, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | February 13, 2025 | |
Alnylam Pharmaceuticals, Inc. | 10-K | February 13, 2025 | |
Alnylam Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | October 31, 2024 | |
Alnylam Pharmaceuticals, Inc. | 8-K | October 31, 2024 | |
Alnylam Pharmaceuticals, Inc. | 8-K | August 1, 2024 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | August 1, 2024 | |
Alnylam Pharmaceuticals, Inc. | 8-K | May 20, 2024 | |
Alnylam Pharmaceuticals, Inc. | 8-K | May 2, 2024 | |
Alnylam Pharmaceuticals, Inc. | 10-Q | May 2, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.